ATE324108T1 - Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung - Google Patents

Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Info

Publication number: ATE324108T1
Authority: AT; Austria
Prior art keywords: carbamat; prevention; compounds; treatment; phenyl
Prior art date: 2001-02-27

Application number

AT02724984T

Other languages

English (en)

Inventor

Carlos R Plata-Salaman

Boyu Zhao

Roy E Twyman

Yong Moon Choi

Robert Gordon

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2006-05-15

2002-02-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2006-05-15 Application granted granted Critical

2006-05-15 Publication of ATE324108T1 publication Critical patent/ATE324108T1/de

Links

208000020925 Bipolar disease Diseases 0.000 title abstract 2
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical class NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 title 1
230000002265 prevention Effects 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
239000011630 iodine Substances 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyridine Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT02724984T 2001-02-27 2002-02-21 Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung ATE324108T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27168101P	2001-02-27	2001-02-27
PCT/US2002/005297 WO2002067921A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating bipolar disorder
US10/081,766 US6562867B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number	Publication Date
ATE324108T1 true ATE324108T1 (de)	2006-05-15

Family

ID=26765948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02724984T ATE324108T1 (de)	2001-02-27	2002-02-21	Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung

Country Status (26)

Country	Link
US (1)	US6562867B2 (de)
EP (1)	EP1408953B1 (de)
JP (1)	JP4276837B2 (de)
KR (1)	KR100946944B1 (de)
CN (1)	CN1250215C (de)
AT (1)	ATE324108T1 (de)
BR (1)	BR0207644A (de)
CA (1)	CA2439475C (de)
CY (1)	CY1105330T1 (de)
CZ (1)	CZ20032300A3 (de)
DE (1)	DE60210976T2 (de)
DK (1)	DK1408953T3 (de)
ES (1)	ES2262801T3 (de)
HU (1)	HUP0303243A3 (de)
IL (1)	IL157590A0 (de)
MX (1)	MXPA03007717A (de)
MY (1)	MY129304A (de)
NO (1)	NO20033802L (de)
NZ (1)	NZ527988A (de)
PL (1)	PL364638A1 (de)
PT (1)	PT1408953E (de)
RS (1)	RS50677B (de)
RU (1)	RU2300372C2 (de)
TW (1)	TWI250872B (de)
WO (1)	WO2002067921A1 (de)
ZA (1)	ZA200307465B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ2003445A3 (cs) *	2000-07-21	2004-08-18	Ortho@Mcneilápharmaceuticalźáinc	Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy
MXPA03007720A (es)	2001-02-27	2004-11-12	Johnson & Johnson	Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
PT1383489E (pt) *	2001-02-27	2007-06-21	Ortho Mcneil Pharm Inc	Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
PT1408954E (pt)	2001-07-16	2009-07-28	Ortho Mcneil Janssen Pharm	Compostos carbamatos para utilização na prevenção ou tratamento da dor neuropática
EA200700642A1 (ru) *	2004-09-16	2007-10-26	Янссен Фармацевтика, Н. В.	Способы лечения эпилептогенеза и эпилепсии
ES2435403T3 (es)	2005-06-08	2013-12-19	Sk Biopharmaceuticals Co., Ltd.	Tratamiento de trastornos del sueño y vigilia
US20070021501A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods of treating epileptogenesis
JP2010508355A (ja) *	2006-10-30	2010-03-18	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	鬱病を処置する方法
WO2008054984A1 (en) *	2006-10-31	2008-05-08	Janssen Pharmaceutica, N.V.	Treatment of pervasive developmental disorders
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US9907776B2 (en) *	2013-03-12	2018-03-06	Bio-Pharm Solutions, Co., Ltd.	Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
US10195151B2 (en)	2016-09-06	2019-02-05	Jazz Pharmaceuticals International Iii Limited	Formulations of (R)-2-amino-3-phenylpropyl carbamate
MY199104A (en)	2016-12-14	2023-10-13	Sk Biopharmaceuticals Co Ltd	Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
AU2018278332B2 (en)	2017-06-02	2022-05-19	Jazz Pharmaceuticals Ireland Limited	Methods and compositions for treating excessive sleepiness
US10940133B1 (en)	2020-03-19	2021-03-09	Jazz Pharmaceuticals Ireland Limited	Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
NZ284846A (en) *	1994-06-16	1998-12-23	Pfizer	1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 CA CA2439475A patent/CA2439475C/en not_active Expired - Fee Related
- 2002-02-21 DK DK02724984T patent/DK1408953T3/da active
- 2002-02-21 WO PCT/US2002/005297 patent/WO2002067921A1/en not_active Ceased
- 2002-02-21 IL IL15759002A patent/IL157590A0/xx not_active IP Right Cessation
- 2002-02-21 CN CNB028089170A patent/CN1250215C/zh not_active Expired - Fee Related
- 2002-02-21 JP JP2002567288A patent/JP4276837B2/ja not_active Expired - Lifetime
- 2002-02-21 RS YUP-678/03A patent/RS50677B/sr unknown
- 2002-02-21 NZ NZ527988A patent/NZ527988A/en unknown
- 2002-02-21 RU RU2003128997/14A patent/RU2300372C2/ru active
- 2002-02-21 ES ES02724984T patent/ES2262801T3/es not_active Expired - Lifetime
- 2002-02-21 CZ CZ20032300A patent/CZ20032300A3/cs unknown
- 2002-02-21 BR BR0207644-6A patent/BR0207644A/pt not_active Application Discontinuation
- 2002-02-21 PL PL02364638A patent/PL364638A1/xx not_active Application Discontinuation
- 2002-02-21 HU HU0303243A patent/HUP0303243A3/hu unknown
- 2002-02-21 EP EP02724984A patent/EP1408953B1/de not_active Expired - Lifetime
- 2002-02-21 AT AT02724984T patent/ATE324108T1/de active
- 2002-02-21 PT PT02724984T patent/PT1408953E/pt unknown
- 2002-02-21 MX MXPA03007717A patent/MXPA03007717A/es active IP Right Grant
- 2002-02-21 DE DE60210976T patent/DE60210976T2/de not_active Expired - Lifetime
- 2002-02-21 KR KR1020037011296A patent/KR100946944B1/ko not_active Expired - Lifetime
- 2002-02-21 US US10/081,766 patent/US6562867B2/en not_active Expired - Lifetime
- 2002-02-27 MY MYPI20020691A patent/MY129304A/en unknown
- 2002-02-27 TW TW091103500A patent/TWI250872B/zh active
2003
- 2003-08-26 NO NO20033802A patent/NO20033802L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307465A patent/ZA200307465B/en unknown
2006
- 2006-06-21 CY CY20061100844T patent/CY1105330T1/el unknown

Also Published As

Publication number	Publication date
TWI250872B (en)	2006-03-11
WO2002067921A1 (en)	2002-09-06
CN1250215C (zh)	2006-04-12
IL157590A0 (en)	2004-03-28
CY1105330T1 (el)	2010-03-03
CA2439475C (en)	2010-05-18
US6562867B2 (en)	2003-05-13
HUP0303243A3 (en)	2012-07-30
CA2439475A1 (en)	2002-09-06
ES2262801T3 (es)	2006-12-01
DE60210976T2 (de)	2007-05-24
DE60210976D1 (de)	2006-06-01
BR0207644A (pt)	2004-03-09
HK1063436A1 (en)	2004-12-31
DK1408953T3 (da)	2006-08-21
NO20033802D0 (no)	2003-08-26
US20020198257A1 (en)	2002-12-26
NO20033802L (no)	2003-10-22
HUP0303243A2 (hu)	2004-01-28
JP4276837B2 (ja)	2009-06-10
PL364638A1 (en)	2004-12-13
ZA200307465B (en)	2005-03-17
KR20030087010A (ko)	2003-11-12
RU2003128997A (ru)	2005-03-20
EP1408953A1 (de)	2004-04-21
YU67803A (sh)	2006-08-17
PT1408953E (pt)	2006-07-31
RS50677B (sr)	2010-06-30
MXPA03007717A (es)	2005-11-08
NZ527988A (en)	2006-01-27
EP1408953B1 (de)	2006-04-26
MY129304A (en)	2007-03-30
JP2004533415A (ja)	2004-11-04
CN1505506A (zh)	2004-06-16
CZ20032300A3 (cs)	2005-01-12
RU2300372C2 (ru)	2007-06-10
KR100946944B1 (ko)	2010-03-15

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1408953

Country of ref document: EP

Publication	Publication Date	Title
NO20071921L (no)	2007-06-12	Fremgangsmater for behandling av epileptogenese og epilepsi
ATE324108T1 (de)	2006-05-15	Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
YU67703A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en)	2009-04-30	Carbamate compounds for use in preventing or treating neurodegenerative disorders
ATE378046T1 (de)	2007-11-15	Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
ATE324107T1 (de)	2006-05-15	Carbamat-verbindungen zur prävention oder behandlung von angstzuständen
ATE538784T1 (de)	2012-01-15	Verfahren zur behandlung von substanzbedingten erkrankungen
ATE267629T1 (de)	2004-06-15	Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
DE60232796D1 (de)	2009-08-13	Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
MY136733A (en)	2008-11-28	Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en)	2008-09-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain